Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
ENHANCEMENT TECHNOLOGIES AND THE BODY
- Linda F. Hogle
- Sociology
- 16 September 2005
AbstractThe technological ability to alter biology, along with the social conditions and cultural expectations that enable such transformations, is spawning a variety of techniques that augment… Expand
Recovering the Nation's Body: Cultural Memory, Medicine, and the Politics of Redemption
- R. Lemmons, Linda F. Hogle
- Sociology
- 1 September 1999
"In this provocative ethnography, Hogle reveals how the uses of human tissue and organs as therapeutic agents are intimately related not only to expanding arenas of commodification, but also to the… Expand
Standardization across Non-standard Domains: The Case of Organ Procurement
- Linda F. Hogle
- Sociology
- 1 October 1995
This article describes the work of negotiating and reinterpreting "standard" protocols and criteria at the level of local practice, using the example of the procurement of human cadaver organs for… Expand
Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field
- L. Fatehi, S. Wolf, +20 authors S. Wickline
- Medicine
- The Journal of law, medicine & ethics : a journal…
- 1 December 2012
Nanotherapeutics and in vivo nanodiagnostics are a subset of nanomedicine applications that includes drugs, biological products, and implantable medical devices incorporating nanoscale materials.… Expand
Pragmatic Objectivity and the Standardization of Engineered Tissues
- Linda F. Hogle
- Computer Science
- 17 September 2009
TLDR
Characterizing human embryonic stem cells: biological and social markers of identity.
- Linda F. Hogle
- Biology, Medicine
- Medical anthropology quarterly
- 1 December 2010
Human embryonic stem cells are elusive, recalcitrant entities that resist characterization and standardization. Without agreements about what the cells are and how best to systematize cell culture… Expand
The social production of evidence: regenerative medicine and the 21st Century Cures Act.
- Linda F. Hogle, Amritava Das
- Medicine
- Regenerative medicine
- 1 September 2017
Regenerative medicine (RM) has experienced uncertainty in regulatory review since the beginning. Political and social environments always affect policy: consistency and interoperability across… Expand
Science, Ethics, and the “Problems” of Governing Nanotechnologies
- Linda F. Hogle
- Medicine, Sociology
- The Journal of law, medicine & ethics : a journal…
- 1 December 2009
Commentators continue to weigh in on whether there are ethical, social, and policy issues unique to nanotechnology, whether new regulatory schemes should be devised, and if so, how. Many of these… Expand
Réglementer les innovations utilisant des tissus humains : hybrides et gouvernance
- Linda F. Hogle
- Sociology
- 28 November 2000
Les innovations medicales qui utilisent des cellules ou des tissus humains constituent un des segments du marche medical dont la croissance est la plus rapide. Grâce a de nouvelles techniques, ces… Expand
Chemoprevention for Healthy Women: Harbinger of Things to Come?
- Linda F. Hogle
- Medicine
- 1 July 2001
Chemoprevention is a new form of medicalization in which healthy individuals take medications to reduce their risk of getting a disease. For the first time, a cancer chemotherapy agent has been… Expand